CAMBRIDGE, Mass – March 30, 2011 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced that Steven Ertel, Senior Vice President Corporate Development, will provide a corporate presentation at the Needham & Company 10th Annual Healthcare Conference and John Knopf, Ph.D., Chief Executive Officer, will provide a corporate presentation at the BioCentury/Thomson Reuters 18th Annual Future Leaders in the Biotech Industry Conference. The details for each presentation are shown below.
Needham & Company 10th Annual Healthcare Conference
Date: Tuesday April 5, 2011
Location: The New York Palace Hotel, New York City
Time: 1:20 to 1:40 PM (EDT)
BioCentury/Thomson Reuters 18th Annual Future Leaders in the Biotech Industry Conference
Date: Friday April 15, 2011
Location: Millennium Broadway Hotel, New York City (Room 508)
Time: 2:30 to 2:55 PM (EDT)
About Acceleron Pharma
Acceleron is a privately-held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of red blood cells, bone, muscle, fat and the vasculature to treat neuromuscular and cancer-related diseases. Acceleron’s scientific approach takes advantage of its unique insight into the regenerative powers of the TGF-β superfamily of proteins. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company’s internal GMP manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron include Advanced Technology Ventures, Alkermes, Bessemer Ventures, Celgene, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. For further information on Acceleron Pharma, please visit www.acceleronpharma.com
CONTACT:
Acceleron Pharma:
Steven Ertel, 617-649-9234
Senior Vice President, Corporate Development
Maureen L. Suda (Media)
Suda Communications LLC
585-387-9248